JP2005500029A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500029A5
JP2005500029A5 JP2003503798A JP2003503798A JP2005500029A5 JP 2005500029 A5 JP2005500029 A5 JP 2005500029A5 JP 2003503798 A JP2003503798 A JP 2003503798A JP 2003503798 A JP2003503798 A JP 2003503798A JP 2005500029 A5 JP2005500029 A5 JP 2005500029A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleotide sequence
group
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003503798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500029A (ja
Filing date
Publication date
Priority claimed from FR0107588A external-priority patent/FR2825716B1/fr
Application filed filed Critical
Publication of JP2005500029A publication Critical patent/JP2005500029A/ja
Publication of JP2005500029A5 publication Critical patent/JP2005500029A5/ja
Pending legal-status Critical Current

Links

JP2003503798A 2001-06-11 2002-06-11 IFNα−7遺伝子の新規ポリヌクレオチド及びポリペプチド Pending JP2005500029A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0107588A FR2825716B1 (fr) 2001-06-11 2001-06-11 Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
PCT/EP2002/007456 WO2002101048A2 (en) 2001-06-11 2002-06-11 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE

Publications (2)

Publication Number Publication Date
JP2005500029A JP2005500029A (ja) 2005-01-06
JP2005500029A5 true JP2005500029A5 (https=) 2005-09-22

Family

ID=8864156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003503798A Pending JP2005500029A (ja) 2001-06-11 2002-06-11 IFNα−7遺伝子の新規ポリヌクレオチド及びポリペプチド

Country Status (6)

Country Link
US (1) US7399464B2 (https=)
EP (1) EP1395684A2 (https=)
JP (1) JP2005500029A (https=)
AU (1) AU2002317867A1 (https=)
FR (1) FR2825716B1 (https=)
WO (1) WO2002101048A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
FR2822845B1 (fr) * 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN113166261A (zh) 2018-10-11 2021-07-23 印希比股份有限公司 B7h3单域抗体及其治疗性组合物
JP7611820B2 (ja) 2018-10-11 2025-01-10 インヒブルクス バイオサイエンシズ インコーポレイテッド Dll3シングルドメイン抗体およびその治療用組成物
JP2022504802A (ja) 2018-10-11 2022-01-13 インヒブルクス インコーポレイテッド 5t4シングルドメイン抗体およびその治療組成物
CN120623346A (zh) 2018-10-11 2025-09-12 因荷布瑞克斯生物科学公司 Pd-1单结构域抗体及其治疗组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
ZA814375B (en) 1980-07-01 1982-07-28 Hoffmann La Roche Interferons and process for their preparation
JPH064673B2 (ja) 1980-11-10 1994-01-19 ゲネンテツク・インコ−ポレ−テツド ハイブリド型ヒト白血球インタフエロン
EP0072541A3 (en) 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
US4801685A (en) * 1981-08-14 1989-01-31 Hoffmann-La Roche Inc. Microbial production of mature human leukocyte interferon K and L
US4810645A (en) 1981-08-14 1989-03-07 Hoffmann-La Roche Inc. Microbial production of mature human leukocyte interferon K and L
US4678751A (en) 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
GB2108510B (en) 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
US5098703A (en) 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
WO1983002460A1 (en) 1982-01-15 1983-07-21 Cetus Corp Interferon-alpha 74
IE54592B1 (en) 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
CA1217440A (en) 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
IL71555A (en) 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
SE8502430L (sv) 1985-05-15 1986-11-16 Kabivitrum Ab En cdna-molekyl som kodar for expressionen av en polypeptid av typen interferon alfa, en bakteriell eller celluler verd transformerad med en sadan molekyl och en polypeptid som uppvisar interferonaktivetet framstelld me
SU1703690A1 (ru) 1986-04-30 1992-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Рекомбинантна плазмидна ДНК @ 22, кодирующа синтез интерферона @ -11 человека, и штамм бактерии РSеUDомоNаS Sp. -продуцент- интерферона @ -11 человека
US5780021A (en) 1993-03-05 1998-07-14 Georgetown University Method for treating type 1 diabetes using α-interferon and/or β-i
CA2164811A1 (en) 1993-06-11 1994-12-22 Sidney Pestka Super proteins including interferons and interleukins
US6001589A (en) 1993-06-11 1999-12-14 Pbl Biomedical Laboratories, Inc. Method of identifying proteins modified by disease states related thereto
WO2000039280A2 (en) * 1998-12-31 2000-07-06 Viragen, Inc. Leukocyte-derived interferon preparations
US20040002474A1 (en) * 1999-10-07 2004-01-01 Maxygen Inc. IFN-alpha homologues
WO2001025438A2 (en) * 1999-10-07 2001-04-12 Maxygen, Inc. Ifn-alpha homologues
US7666995B2 (en) * 2000-11-03 2010-02-23 Pestka Biomedical Laboratories Interferons, uses and compositions related thereto
JPWO2002069913A1 (ja) 2001-03-01 2004-09-09 株式会社クリニカルコスメティック 皮膚改善用組成物セット

Similar Documents

Publication Publication Date Title
Fletcher et al. Transcriptomic analysis of the woodchuck model of chronic hepatitis B
Crow et al. Microarray analysis of interferon-regulated genes in SLE
Kaiser et al. Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease
Bataller et al. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal
JP2004533240A5 (https=)
Snoussi et al. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma
JP2022524212A (ja) 操作されたmRNA配列及びその使用
RU2003133982A (ru) Новые полинуклеотиды и полипептиды гена ifn альфа-17
Zhang et al. Effector CD4+ T cell expression signatures and immune-mediated disease associated genes
JP2017532961A5 (https=)
Zayed et al. Association of toll-like receptor 3 and toll-like receptor 9 single nucleotide polymorphisms with hepatitis C virus infection and hepatic fibrosis in egyptian patients
Haugland et al. Differential expression profiles and gene structure of two tumor necrosis factor-α variants in Atlantic salmon (Salmo salar L.)
Rani et al. Novel interferon-β-induced gene expression in peripheral blood cells
JP2005500029A5 (https=)
Urosevic et al. Type I IFN innate immune response to adenovirus-mediated IFN-γ gene transfer contributes to the regression of cutaneous lymphomas
JP2004535196A5 (https=)
CN109504763B (zh) 用于预测α干扰素治疗乙肝患者疗效的分子标记
CN114921542A (zh) 一种与病毒性肝炎抗病毒治疗应答预测相关的snp分子标记及其应用
CN110734974B (zh) 一种癌症化疗用药snp位点组合以及检测引物
Li et al. Analysis of lncRNA, miRNA, and mRNA expression profiling in type I IFN and type II IFN overexpressed in porcine alveolar macrophages
Xiang et al. Liver transcriptome analysis of the Sparus macrocephlus in response to Vibrio parahaemolyticus infection
JP2025098004A (ja) マクロファージ刺激1受容体(mst1r)バリアント及びその使用
JP2005500029A (ja) IFNα−7遺伝子の新規ポリヌクレオチド及びポリペプチド
Sivaprasad et al. The distribution of genotype and allelic frequency of IL28B gene polymorphism in Andhra Pradesh, India
Zhang et al. De novo RNA-seq assembly and differential transcriptome analysis of Carassius auratus gibelio after Cyprinid herpesvirus 2 infection